Cannabix Technologies Inc. develops marijuana breathalyzers aimed at employers and law enforcement in North America. While the company has a strong liquidity position with a current ratio of 6.44 and minimal debt (0.03 debt/equity), it faces significant challenges with negative margins across gross, EBITDA, and net metrics, indicating operational inefficiencies. The gross margin of -177.7% raises concerns about profitability potential. Overall, the company’s innovative product could have market potential, but financial health needs substantial improvement.
Loading financial metrics...
Company has $708K in cash but burned $467K last quarter. At this burn rate, only 1.5 quarters of runway remain without additional financing.
Company posted a loss of $-6.3M over the last year, representing 3951.3% of revenue.
Operating cash flow has been negative for 3 consecutive quarters, burning $1.9M over the last year.
Fortress balance sheet: cash covers total debt 14×, providing significant financial flexibility.
Excellent liquidity with current ratio of 6.4x ensures operational stability.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Medical - Devices companies of a similar size
Based on 2026-Q3 (January 31, 2026)